Access Is Power: Opioid Use Disorder and Reproductive Health

Fact Sheet

Access Is Power: Opioid Use Disorder and Reproductive Health

Generic Fact Sheet image

As the incidence of opioid use disorder in pregnancy has increased, so too has the number of infants born with neonatal abstinence syndrome (NAS). Women with opioid use disorder are at increased risk for unplanned pregnancy. Given this increased risk, one primary prevention strategy for reducing the incidence of NAS and utilization of the foster system that states and communities should consider is to address the reproductive health needs of individuals with substance use disorder (SUD). For women not in recovery, many barriers including cost, fear of mistreatment, and lack of transportation, contribute to a high rate of unplanned pregnancy. Even for those in recovery, barriers remain. This brief highlights several state and local initiatives to increase knowledge about, and access to, reproductive health services for women with SUD.

July 2018

Related Resources

Fact Sheet
In 2021, Title X-supported clinics provided contraceptive care to 77,007 women in Florida. The number of women served from 2018-2021 declined by 27.7%.
Fact Sheet
All Title X-supported clinics in Maine were forced to leave the program as a result of the gag rule.
Fact Sheet
In 2021, Title X-supported centers provided contraceptive care to 169,274 women in Texas. The number of patients served from 2018-2021 increased by 7.6%.
Fact Sheet
In 2021, Title X-supported centers provided contraceptive care to 33,001 women in New Jersey. The number of women served from 2018-2021 declined by 65.7%.